Optineurin suppression causes neuronal cell death via NF-κB pathway

Journal of Neurochemistry

Volumn 126, Issue 6, 2013, Pages 699-704

  Akizuki, Mayumi ^a   Yamashita, Hirofumi ^a   Uemura, Kengo ^a   Maruyama, Hirofumi ^b   Kawakami, Hideshi ^b   Ito, Hidefumi ^a   Takahashi, Ryosuke ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

amyotrophic lateral sclerosis; NF B; optineurin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OPTINEURIN; SMALL INTERFERING RNA; WITHAFERIN A;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; MITOCHONDRION; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTN GENE; PRIORITY JOURNAL; PROTEIN FUNCTION;

AMYOTROPHIC LATERAL SCLEROSIS; NF-ΚB; OPTINEURIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CELL COUNT; CELL DEATH; CELLS, CULTURED; COLORING AGENTS; EYE PROTEINS; GENES, P53; GENES, REPORTER; LUCIFERASES; MICE; MUTATION; NEURONS; NF-KAPPA B; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TRYPAN BLUE; TUMOR NECROSIS FACTOR-ALPHA; WITHANOLIDES;

EID: 84883739501     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12326     Document Type: Article

References (23)

1. Belzil V. V., Daoud H., Desjarlais A., Bouchard J. P., Dupre N., Camu W., Dion P. A., and, Rouleau G. A., (2011) Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis. Neurobiol. Aging 32, 555.e13-555.e14.
2. Chi Z. L., Akahori M., Obazawa M., et al,. (2010) Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum. Mol. Genet. 19, 2606-2615.
3. Clemens J. A., (2000) Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic. Biol. Med. 28, 1526-1531.
4. Del Bo R., Tiloca C., Pensato V., et al,. (2011) Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 82, 1239-1243.
5. Gould T. W., Buss R. R., Vinsant S., Prevette D., Sun W., Knudson C. M., Milligan C. E., and, Oppenheim R. W., (2006) Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26, 8774-8786.
6. Hensley K., Fedynyshyn J., Ferrell S., et al,. (2003) Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 14, 74-80.
7. Ito H., Fujita K., Nakamura M., et al,. (2011) Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol. 121, 555-557.
8. Le Bail O., Schmidt-Ullrich R., and, Israel A., (1993) Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 12, 5043-5049.
9. LePage K. T., Dickey R. W., Gerwick W. H., Jester E. L., and, Murray T. F., (2005) On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies. Crit. Rev. Neurobiol. 17, 27-50.
10. Li H., Ao X., Jia J., Wang Q., and, Zhang Z., (2011) Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells. Mol. Vis. 17, 3314-3325.
11. Martin L. J., (2000) p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 7, 613-622.
12. Maruyama H., Morino H., Ito H., et al,. (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223-226.
13. Millecamps S., Boillee S., Chabrol E., et al,. (2011) Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol. Aging 32, 557.e11-557.e13.
14. Miyashita T., and, Reed J. C., (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
15. Osawa T., Mizuno Y., Fujita Y., Takatama M., Nakazato Y., and, Okamoto K., (2011) Optineurin in neurodegenerative diseases. Neuropathology 31, 569-574.
16. Poloni M., Facchetti D., Mai R., et al,. (2000) Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 287, 211-214.
17. Rezaie T., Child A., Hitchings R., et al,. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295, 1077-1079.
18. Rosen D. R., Siddique T., Patterson D., et al,. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
19. Sahlender D. A., Roberts R. C., Arden S. D., Spudich G., Taylor M. J., Luzio J. P., Kendrick-Jones J., and, Buss F., (2005) Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J. Cell Biol. 169, 285-295.
20. Sippl C., Bosserhoff A. K., Fischer D., and, Tamm E. R., (2011) Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp. Eye Res. 93, 669-680.
21. Swarup V., Phaneuf D., Dupre N., Petri S., Strong M., Kriz J., and, Julien J. P., (2011) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J. Exp. Med. 208, 2429-2447.
22. Tumer Z., Bertelsen B., Gredal O., Magyari M., Nielsen K. C., LuCamp, Gronskov K., and, Brondum-Nielsen K., (2012) A novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Neurobiol. Aging 33, 208.e1-208.e5.
23. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M., and, Sobue G., (2002) Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80, 158-167.